|
THOC2 expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 1.141620E-02 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.622020E-02 |
| Normal-vs-Stage2 |
4.898400E-02 |
| Normal-vs-Stage3 |
1.329990E-02 |
| Normal-vs-Stage4 |
5.372200E-02 |
| Stage1-vs-Stage2 |
6.247000E-01 |
| Stage1-vs-Stage3 |
5.733800E-01 |
| Stage1-vs-Stage4 |
8.278200E-01 |
| Stage2-vs-Stage3 |
8.852000E-01 |
| Stage2-vs-Stage4 |
8.032000E-01 |
| Stage3-vs-Stage4 |
8.653000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
2.090300E-02 |
| Normal-vs-AfricanAmerican |
2.199600E-04 |
| Normal-vs-Asian |
3.144400E-01 |
| Caucasian-vs-AfricanAmerican |
1.840390E-02 |
| Caucasian-vs-Asian |
8.057900E-02 |
| AfricanAmerican-vs-Asian |
1.057930E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.283600E-03 |
| Normal-vs-Female |
4.024100E-02 |
| Male-vs-Female |
2.680600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
9.817400E-03 |
| Normal-vs-Age(41-60Yrs) |
1.138790E-01 |
| Normal-vs-Age(61-80Yrs) |
2.319400E-03 |
| Normal-vs-Age(81-100Yrs) |
4.393900E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.440630E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.312000E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.682600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.370000E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
1.913590E-02 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.193600E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
5.084400E-01 |
| Normal-vs-Grade 2 |
1.538160E-01 |
| Normal-vs-Grade 3 |
4.28590000000062E-05 |
| Normal-vs-Grade 4 |
1.134430E-01 |
| Grade 1-vs-Grade 2 |
1.958600E-01 |
| Grade 1-vs-Grade 3 |
4.823100E-03 |
| Grade 1-vs-Grade 4 |
2.004800E-01 |
| Grade 2-vs-Grade 3 |
1.418260E-03 |
| Grade 2-vs-Grade 4 |
5.650200E-01 |
| Grade 3-vs-Grade 4 |
2.212800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
3.507400E-01 |
| Normal-vs-ccB subtype |
2.082500E-03 |
| ccA subtype-vs-ccB subtype |
3.358600E-03 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.528480E-02 |
| Normal-vs-N1 |
6.480500E-02 |
| N0-vs-N1 |
5.684200E-01 |
|
|
